American Esthetician Organization
SEPTEMBER 13, 2023
But did you know that this lucrative market not only affects the world of pet products but also has a significant impact on the skincare industry ? In this article, we’ll delve into the fascinating connection between the pet industry and the skincare market, exploring the growth, trends, and influence they have on each other.
Renee Rouleau
JULY 28, 2023
This really got me thinking—as Head of New Product Development at my company, it’s always been my responsibility to ensure the safety and quality of our products. But when a product is already out on the market and starts to exhibit these types of issues, it’s a whole other story. We can solve for that.
Les Nouvelles Esthetics & Spa
FEBRUARY 29, 2024
Inclusivity and client safety are key in the design of these systems. Ensuring that practices are accessible to all clients, regardless of background, and that safety protocols are rigorously maintained, is essential. By prioritizing client experience and operational efficiency, practices can distinguish themselves in a crowded market.
Kim Gallo Esthetics
FEBRUARY 27, 2024
The accessibility of tools and treatments prompts questions about their efficacy and safety, reminding us to trust professionals for guidance and comprehensive understanding. Many skincare brands use terms like "organic" or "natural" as marketing tactics, without any scientific evidence to support their claims.
The Eco Well Blog
JUNE 14, 2024
Or are they putting these guides out as a fear marketing campaign to promote the EWG seal program (which makes them money)? But hopefully it gives you the gist of why it’s unreliable and why I’ve come to the conclusion that these guides are part of a greater marketing campaign by the EWG. market while tests are still being conducted.
The Dermatology Digest
JULY 22, 2024
Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. We are delighted at the launch of Uzpruvo in Europe and to be first-to-market,” adds Robert Wessman, Chief Executive Officer of Alvotech.
The Dermatology Digest
FEBRUARY 27, 2024
While both low-concentration and high-concentration strength biosimilars of Humira are marketed in the U.S. We strongly believe that biosimilars are important in addressing inflationary pressures in the healthcare system across all markets, especially in the U.S. Both Alvotech and Teva expect to launch SIMLANDI in the U.S.
Expert insights. Personalized for you.
164 
Let's personalize your content